skip to main content

ICS and pneumonia risk in COPD — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateRespiratory TherapeuticsICS and pneumonia risk in COPDGPhC CRA

A 73-year-old man with COPD collects a triple-therapy inhaler containing an inhaled corticosteroid. He has had two exacerbations this year and asks what side effects he should watch for. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Report symptoms of pneumonia such as fever, increased breathlessness or purulent sputum

Inhaled corticosteroids can increase pneumonia risk in people with COPD, particularly in older patients and those with severe disease. The patient should know to seek advice for infective symptoms. Mouth rinsing also reduces local candidiasis risk. Routine antifungal prophylaxis is not needed.

Reference: BNF; NICE CKS